试验透明度

As an essential part of our clinical trial governance, we are committed to elevating your experience with constant communication and data transparency.

Open communication

Collaborative and proactive, our research teams prioritize open communication with stakeholders throughout trials to help you make the right decisions at the right time.

Clarity

We use data and technology to provide personalized, transparent experiences.

Our proprietary technology Clarity is used as standard across all trials we support and fits seamlessly into your existing workflow so you can see how your study is progressing and how your patient data is performing. It does this through simplified data collection with EDC to CTMS to safety database integration and a continuous flow of information that enables data transparency and a secure, holistic view of your clinical study progress near real-time.

This holistic view allows integrated teams within Caidya to transparently share information and data, generating and sharing insights to inform your decisions.

Learn more about Clarity
Gateway to the globe

Speak to a global expert

Discover how our technology and data integration solutions help you safely and efficiently progress your clinical studies with confidence.

联系我们
引领创新

康缔亚最新动态

探索我们的新闻动态,体验卓越服务品质

02/24/2026

康缔亚任命 Michael Clay 为首席运营官,推动卓越运营并提升国际多中心临床开发服务能力

美国北卡罗来纳州罗利,2026年2月17日 —— 专注于为创新生物制药企业加速临床开发的全球领先中型合同研究组织(CRO)康缔亚宣布任命 Michael Clay 为首席运营官。Clay 将领导康缔亚...

02/10/2026

康缔亚强化欧洲增长战略

美国北卡罗来纳州罗利,2026年2月10日 —— 专注为创新生物制药企业加速临床开发的领先全球中型临床合同研究组织(CRO)康缔亚今日宣布,任命 Mario Bautista 为欧洲业务拓展负责人。在...

12/22/2025

康缔亚潘文卿入选《法律500强》GC Powerlist China 2025榜单

2025年12月22日,北卡罗来纳州罗利及上海——全球领先的中型临床研究服务供应商(CRO)康缔亚今日宣布,公司中国区法务负责人、执行总监潘文卿(Miles Pan)入选《法律500强》GC Powe...
Skip to toolbar